Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Biotech
Lilly lands next-gen pain asset in $1B SiteOne acquisition
SiteOne's lead sodium channel inhibitor was well-tolerated and improved patients' pain tolerances in a recent phase 1 trial.
Darren Incorvaia
May 27, 2025 11:30am
Julius attaches roots to Peachtree in CRO merger
May 14, 2025 2:52pm
Recursion streamlines pipeline following merger with Exscientia
May 5, 2025 11:00am
Concentra swoops in to purchase struggling Kronos
May 1, 2025 3:07pm
Alis wants to free capital 'trapped' at struggling biotechs
Apr 18, 2025 9:45am
Expect further market correction in tariff-driven era: PitchBook
Apr 18, 2025 7:51am
